BMY vs MNTN · P/E 17, rev $24.46B vs rev $290.1M
Bristol-Myers Squibb Company (BMY) versus MNTN, Inc. (MNTN) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
MNTN, Inc. (MNTN) is a software - application company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported MNTN revenue for 2025-12-31 was $290.1M. Net income was -$6.4M. Revenue was up 28.6% from 2024-12-31 to 2025-12-31. MNTN currently screens at market cap $0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. MNTN currently screens at market cap $0.
Not investment advice. Open the BMY and MNTN stock pages for the full models.
Not investment advice.